Delaware Bankruptcy Court

Case number: 1:22-bk-11294 - Clovis Oncology Ireland Limited - Delaware Bankruptcy Court

Case Information
Case title
Clovis Oncology Ireland Limited
Chapter
11
Judge
J Kate Stickles
Filed
12/11/2022
Last Filing
10/24/2024
Asset
Yes
Vol
v
Docket Header

JNTADMN, CLMSAGNT




U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 22-11294-JKS

Assigned to: Bankruptcy Judge J Kate Stickles
Chapter 11
Voluntary
Asset


Date filed:  12/11/2022

Debtor

Clovis Oncology Ireland Limited

1st Floor, Building Two
The Green Dublin Airport Central
Dublin Airport
Swords
OUTSIDE U. S.
Dublin, Ireland
Tax ID / EIN: XX-XXXXXXX

represented by
Robert J. Dehney

Morris, Nichols, Arsht & Tunnell
1201 N. Market Street
P O. Box 1347
Wilmington, DE 19899-1347
(302) 658-9200
Fax : (302) 658-3989
Email: [email protected]

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491

 
 
Claims Agent

Kroll Restructuring Administration LLC

(f/k/a Prime Clerk LLC)
55 East 52nd Street
17th Floor
New York, NY 10055
212-257-5450
 
 

Latest Dockets
Date Filed#Docket Text
12/15/20229Docket Text
An order has been entered in this case in accordance with Bankruptcy Rule 1015(b) directing the procedural consolidation and joint administration of the chapter 11 cases of Clovis Oncology, Inc., Clovis Oncology UK Limited, and Clovis Oncology Ireland Limited. The docket in the chapter 11 case of Clovis Oncology, Inc., Case No. 22-11292 (JKS), should be consulted for all matters affecting these cases. (related document(s)8) (SJM) (Entered: 12/15/2022)
12/14/20228Docket Text
Order Directing Joint Administration of Cases " An order has been entered in this case in accordance with Bankruptcy Rule 1015(b) directing the procedural consolidation and joint administration of the chapter 11 cases of Clovis Oncology, Inc., Clovis Oncology UK Limited, and Clovis Oncology Ireland Limited. The docket in the chapter 11 case of Clovis Oncology, Inc., Case No. 22-11292 (JKS), should be consulted for all matters affecting these cases." Signed on 12/14/2022 (AJL) (Entered: 12/14/2022)
12/12/20227Docket Text
Order Approving Motion for Admission pro hac vice (Related Doc # 5) (related document(s)5) Order Signed on 12/12/2022. (AJL) (Entered: 12/12/2022)
12/12/20226Docket Text
Certificate of Service Certificate of Service to Entry of Appearance and Request for Notices of 3B Pharmaceuticals GmbH Pursuant to Fed. R. Bankr. P. 2002 and 9010 and Del. Bankr. L.R. 2002-1(d) Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/2022Docket Text
Attorney Paul D. Moak and Mark W. Eckard for 3B Pharmaceuticals GmbH added to case Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/20225Docket Text
Motion to Appear pro hac vice of Paul D. Moak. Receipt Number 3908008, Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/20224Docket Text
Notice of Appearance. Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/2022Docket Text
Judge J Kate Stickles added to case (SJS) (Entered: 12/12/2022)
12/12/20223Docket Text
Motion for Joint Administration // Debtors' Motion for Order Authorizing Joint Administration of the Debtors' Chapter 11 Cases Filed By Clovis Oncology Ireland Limited (Attachments: # 1 Exhibit A: Proposed Order)(Dehney, Robert) (Entered: 12/12/2022)
12/11/20222Docket Text
Receipt of filing fee for Voluntary Petition (Chapter 11)( 22-11294) [misc,volp11a] (1738.00). Receipt Number A10932501, amount $1738.00. (U.S. Treasury) (Entered: 12/11/2022)